Back
Plus Therapeutics Vs. Nukkleus Industry Stock Comparison
Sell
38
PSTV
Plus Therapeutics
Last Price:
$1.15
Seasonality Move:
6.33%
Sell
23
NUKK
Nukkleus
Last Price:
$19.00
Seasonality Move:
48.46%
Sell
38
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy, Sell or Hold?
-
The current Plus Therapeutics [PSTV] share price is $1.20. The Score for PSTV is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
PSTV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Nukkleus (NUKK)
is a Sell
Is Nukkleus a Buy, Sell or Hold?
-
NUKK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PSTV Stock Price Chart
What is Plus Therapeutics's stock price today?
-
The Plus Therapeutics share price today is $1.20The current trend is relatively stagnant and PSTV is experiencing slight selling pressure.
NUKK Stock Price Chart
PSTV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 49.93 | Sell |
Chaikin Money Flow: | -36989 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.09 - 1.33) | Sell |
Bollinger Bands (100): | (1.19 - 1.49) | Sell |
NUKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.09 | Buy |
Relative Strength Index (14 RSI): | 48.74 | Sell |
Chaikin Money Flow: | -90986 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.08 - 39.18) | Sell |
Bollinger Bands (100): | (-5.25 - 19.13) | Buy |
PSTV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.2 | Buy |
20-day SMA: | 1.17 | Buy |
50-day SMA: | 1.24 | Sell |
200-day SMA: | 1.6 | Sell |
8-day EMA: | 1.2 | Buy |
20-day EMA: | 1.19 | Buy |
50-day EMA: | 1.25 | Sell |
200-day EMA: | 1.59 | Sell |
NUKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30 | Sell |
20-day SMA: | 26.02 | Sell |
50-day SMA: | 11.64 | Buy |
200-day SMA: | 6.16 | Buy |
8-day EMA: | 27.7 | Sell |
20-day EMA: | 25.09 | Sell |
50-day EMA: | 16.11 | Buy |
200-day EMA: | 13.92 | Buy |
Plus Therapeutics Earnings Growth & PSTV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.33 per share.
Nukkleus Earnings Growth & NUKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Plus Therapeutics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nukkleus Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |